In the ongoing battle against triple negative breast cancer, Vanderbilt researchers have uncovered a promising non-invasive ...

Aging is a privilege, but it also brings risks—including an increased likelihood of developing age-related diseases including ...

It is a useful therapy with several drawbacks that limit its effectiveness, including prolonged light sensitivity, poor ...

Marla Anderson, MD, a board-certified surgeon, shares practical advice for living with metastatic breast cancer and tips for ...

Significant increases in breast cancer incidence were found among Hispanic, American Indian or Alaska Native, and Asian or ...

Kay Quinn's cotton-candy colored hair transformation hopes to raise awareness and support for a breast cancer-free future.

Researchers surveyed survivors of early-stage hormone receptor-positive breast cancer who did not receive chemotherapy to assess the symptom burden in this patient population.

Jan. 15, 2025 — In patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with trastuzumab emtansine (T-DM1) reduced the long-term risk of death or invasive ...

She had no family history of cancer. So when she experienced some swelling in her breast near the end of what she called “a textbook-easy pregnancy” with her third child, she and her doctors ...

Jan. 21, 2025 -- The FDA has approved a new treatment for patients with a common form of breast cancer that has spread to other parts of the body or cannot be surgically removed. The drug ...